Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs

Using the crystal structure of SARS-CoV-2 papain-like protease (PL(pro)) as a template, we developed a pharmacophore model of functional centers of the PL(pro) inhibitor-binding pocket. With this model, we conducted data mining of the conformational database of FDA-approved drugs. This search identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouznetsova, Valentina L., Zhang, Aidan, Tatineni, Mahidhar, Miller, Mark A., Tsigelny, Igor F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505060/
https://www.ncbi.nlm.nih.gov/pubmed/32999768
http://dx.doi.org/10.7717/peerj.9965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505060/
https://www.ncbi.nlm.nih.gov/pubmed/32999768
http://dx.doi.org/10.7717/peerj.9965

Ejemplares similares